NCT03190174 2025-02-17
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Phase 1/2 Completed
Sarcoma Oncology Research Center, LLC
Nektar Therapeutics
Presage Biosciences
Oncovir, Inc.